Evolution in the Surgical Management of Gastric Cancer Peritoneal Metastases

Overview

Journal Cancers (Basel)

Publisher MDPI

Date 2025 Jan 11

PMID 39796727

Authors

Matthew Krell

Suedeh Ranjbar

Saige Gitlin

Diego R Alvarez Vega

Rachel Wilson

Kenya Thrasher

Zachary J Brown

Affiliations

Soon will be listed here.

Abstract

Despite therapeutic treatments and the growing utilization of multimodal therapies, gastric cancer (GC) remains a highly aggressive malignancy with high mortality worldwide. Much of the complexity in treating GC is due to the high incidence of peritoneal metastasis (PM), with mean overall survival typically ranging from 4 to 10 months. With current systemic therapy, targeted therapies, and immunotherapies continuing to remain ineffective for GC/PM, there has been a significant growing interest in intraperitoneal (IP) therapies for the treatment of GC/PM. In this review, we summarize the development of PM and evolving treatment strategies for GC/PM. Furthermore, we explore the various advancements and outcomes of IP therapies, including heated intraperitoneal chemotherapy (HIPEC), neoadjuvant HIPEC, and pressurized intraperitoneal aerosolized chemotherapy (PIPAC).

References

Taibi A, Sgarbura O, Hubner M, Bardet S, Alyami M, Bakrin N . Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study. Ann Surg Oncol. 2022; 29(8):5243-5251. DOI: 10.1245/s10434-022-11577-2. View

Yu H, Yonemura Y, Ng H, Lee M, Su B, Hsieh M . Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery. Cancers (Basel). 2023; 15(13). PMC: 10341196. DOI: 10.3390/cancers15133401. View

Mimouni M, Richard C, Adenot P, Letheule M, Tarrade A, Sandra O . Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model. BMC Cancer. 2021; 21(1):461. PMC: 8073905. DOI: 10.1186/s12885-021-07955-w. View

Ikoma N, Blum M, Chiang Y, Estrella J, Roy-Chowdhuri S, Fournier K . Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. Ann Surg Oncol. 2016; 23(13):4332-4337. DOI: 10.1245/s10434-016-5409-7. View

Khomyakov V, Ryabov A, Ivanov A, Bolotina L, Utkina A, Volchenko N . Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study.... Pleura Peritoneum. 2019; 1(3):159-166. PMC: 6386494. DOI: 10.1515/pp-2016-0017. View

Hubner M, Alyami M, Villeneuve L, Cortes-Guiral D, Nowacki M, So J . Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols. Eur J Surg Oncol. 2021; 48(4):789-794. DOI: 10.1016/j.ejso.2021.10.028. View

Canbay E, Canbay Torun B, Cosarcan K, Altunal C, Gurbuz B, Bilgic C . Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer. J Gastrointest Oncol. 2021; 12(Suppl 1):S47-S56. PMC: 8100720. DOI: 10.21037/jgo-20-121. View

Janjigian Y, Shitara K, Moehler M, Garrido M, Salman P, Shen L . First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021; 398(10294):27-40. PMC: 8436782. DOI: 10.1016/S0140-6736(21)00797-2. View

MUNNELL E . Surgical treatment of ovarian carcinoma. Clin Obstet Gynecol. 1969; 12(4):980-92. DOI: 10.1097/00003081-196912040-00011. View

10.

Kobayashi H, Honda M, Kawamura H, Takiguchi K, Muto A, Yamazaki S . Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination. J Surg Oncol. 2022; 125(4):615-620. DOI: 10.1002/jso.26770. View

11.

Struller F, Horvath P, Solass W, Weinreich F, Strumberg D, Kokkalis M . Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study. Ther Adv Med Oncol. 2019; 11:1758835919846402. PMC: 6535725. DOI: 10.1177/1758835919846402. View

12.

Thomassen I, van Gestel Y, van Ramshorst B, Luyer M, Bosscha K, Nienhuijs S . Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2013; 134(3):622-8. DOI: 10.1002/ijc.28373. View

13.

Tobias J, GRIFFITHS C . Management of ovarian carcinoma. Current concepts and future prospects (first of two parts). N Engl J Med. 1976; 294(15):818-22. DOI: 10.1056/NEJM197604082941506. View

14.

Fujitani K, Yang H, Mizusawa J, Kim Y, Terashima M, Han S . Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016; 17(3):309-318. DOI: 10.1016/S1470-2045(15)00553-7. View

15.

Facchiano E, Scaringi S, Kianmanesh R, Sabate J, Castel B, Flamant Y . Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol. 2007; 34(2):154-8. DOI: 10.1016/j.ejso.2007.05.015. View

16.

Alyami M, Mercier F, Siebert M, Bonnot P, Laplace N, Villeneuve L . Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2019; 47(1):128-133. DOI: 10.1016/j.ejso.2019.06.028. View

17.

Geva R, Alon G, Nathanson M, Bar-David S, Nevo N, Aizic A . PD-1 Blockade Combined with Heated Intraperitoneal Chemotherapy Improves Outcome in Experimental Peritoneal Metastases from Colonic Origin in a Murine Model. Ann Surg Oncol. 2023; 30(5):2657-2663. DOI: 10.1245/s10434-022-13025-7. View

18.

Rau B, Brandl A, Piso P, Pelz J, Busch P, Demtroder C . Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2019; 23(1):11-22. DOI: 10.1007/s10120-019-00978-0. View

19.

Ricco B, Martinelli G, Bardasi C, Dominici M, Spallanzani A, Salati M . Optimizing the Continuum of Care in Gastric Cancer. Onco Targets Ther. 2023; 16:995-1012. PMC: 10680466. DOI: 10.2147/OTT.S365505. View

20.

Karanicolas P, Elkin E, Jacks L, Atoria C, Strong V, Brennan M . Staging laparoscopy in the management of gastric cancer: a population-based analysis. J Am Coll Surg. 2011; 213(5):644-651, 651.e1. DOI: 10.1016/j.jamcollsurg.2011.07.018. View